Send to

Choose Destination
See comment in PubMed Commons below
Transpl Int. 2012 Oct;25(10):1013-23. doi: 10.1111/j.1432-2277.2012.01513.x. Epub 2012 Jun 21.

Anemia and erythrocytosis in patients after kidney transplantation.

Author information

Department of Nephrology and Transplantology, Medical University, Bialystok, Poland.


Anemia is a highly prevalent disorder in recipients of renal allografts. Despite its frequent occurrence, there is still uncertainty with regard to treatment targets and treatment options. This includes questions on appropriate iron management, the choice and dosage of erythropoietin stimulating agents, criteria for the timing of treatment initiation and the targeted hemoglobin values. The review summarizes available data on recent therapeutic strategies for post transplant anemia, as well as for post transplant erythrocytosis, another hematological disorder, that has decreased in recent years.

[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center